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Abstract 
Background: The United States Preventive Services Task Force (USPSTF) issued 
an "I" recommendation in 2004 for screening for intimate partner violence (IPV); 
it found insufficient evidence to recommend in favor of or against screening. This 
recommendation has been criticized. It is inconsistent with the recommendations 
of the American Medical Association and the American College of Obstetrics and 
Gynecology, both of which recommend that clinicians routinely inquire directly 
about a history of abuse. The purpose of this paper is to evaluate whether the "I" 
recommendation is consistent with the evidence that exists for IPV screening and 
whether the criteria used by the USPSTF to evaluate IPV screening were 
comparable to the criteria used for other health topics. 
Methods: I used one set of criteria to evaluate the USPSTF's systematic evidence 
review (SER) on screening for IPV and to compare it to the SER's on screening 
for depression and alcohol misuse. Another set of criteria was used to evaluate 
the USPSTF recommendation for IPV screening and to compare it to other 
USPSTF recommendations. 
Results: There were important differences in the SER's that may have resulted in 
adverse effects being given more weight in determining the benefit-harm ratio in 
the IPV SER than they were given in the other two SER's. However, there was 
significantly less evidence available on IPV screening than for depression or 
alcohol misuse screening. 
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Conclusion: Evidence for screening for IPV may not have been assessed in a 
comparable way to that for depression and alcohol misuse, but due to a shortage 
of evidence on IPV screening, the "I" recommendation would likely stand if 
disparities in the synthesis of the evidence were remedied. 
Background 
USPSTF Recommendations for Screening for Intimate Partner Violence 
The United States Preventive Services Task Force (USPSTF) systematic evidence 
review (SER) for screening for intimate partner violence (IPV) "identified no 
studies that directly addressed the effectiveness of screening in a health care 
setting in reducing harm from family and intimate partner violence or the adverse 
effects of screening and interventions."1 Screening instruments were validated, 
but none were evaluated on violence or health outcomes. Authors of the SER 
stated a need for studies of the effectiveness of treatment programs for survivors 
of violence and perpetrators to demonstrate that identification and intervention 
does or does not lead to improved health outcomes, including reduced violence, 
improved quality of life, mental health, social support, self-esteem, and 
productivity. 
The USPSTF gave screening for IPV an "I" recommendation, which means they 
found insufficient evidence to recommend for or against the routine screening of 
women for intimate partner violence by clinicians. 2 Because of gaps in the 
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evidence, the USPSTF could not determine the balance between the benefits and 
harms of screening for intimate partner violence. 
One Critique of the USPSTF's Recommendation for Screening for IPV 
Dr. Linda Chamberlain is an epidemiologist specializing in the health effects of 
domestic violence who works as a consultant for the Family Violence Prevention 
Fund (FVPF). She wrote an article for FVPF that detailed several criticisms of 
the USPSTF guidelines for IPV. 3 She felt IPV should be evaluated as its own 
topic, rather than being evaluated in the same review with child and elder abuse. 
She also said there should be a separate recommendation on screening pregnant 
women, like USPSTF did for screening for alcohol and tobacco use. Instead, the 
authors dismissed the limited evidence that exists for screening and intervention 
for IPV during pregnancy, rather than lending weight to findings in this high-risk 
group. 
Chamberlain asserted that evaluating IPV as a screening practice forces the topic 
into a medical model that requires a greater burden of evidence than if it had been 
evaluated as a behavioral assessment and counseling practice, which would be a 
more appropriate framework for the evaluation of ways to address IPV. The 
authors excluded trauma studies in order to emphasize screening asymptomatic 
patients, but the USPSTF's previous recommendations emphasized injury-related 
health risks of IPV in the primary care setting. 
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Another problem Chamberlain identified was that authors speculated on potential 
adverse effects of screening based on studies that were not germane to screening 
for IPV. In fact these studies did not meet the inclusion criteria for the SER. She 
asserted that emphasizing theoretical adverse effects of screening without 
considering potential benefits resulted in misleading analysis. The USPSTF did 
not acknowledge the adverse effects of doing nothing to address IPV in the 
primary care setting. The adverse effects of not asking women about IPV should 
be given as much consideration as the adverse effects of screening. Finally, 
Chamberlain stated that other screening services that have been given a favorable 
recommendation by the USPSTF have gaps in the evidence similar to those that 
exist for IPV screening. 
USPSTF Recommendations for Screening for Depression and Alcohol Misuse 
The USPSTF systematic evidence review for screening for depression found that 
the "rate of detection and diagnosis of depression, based mainly on chart reviews 
or the completion of a study-specific form" increased from 37% to 47% in six 
studies that examined the effect of providing feedback of depression screening 
results to primary care providers.4 Among studies with interpretable clinical 
outcomes, screening was associated with 9% absolute reduction in proportion of 
patients with persistent depression. The USPSTF gave screening for depression a 
"B" recommendation, which means that they recommend that clinicians routinely 
screen for depression because there is at least fair evidence that the benefits of 
screening outweigh the harms of screening. 5 Specifically, the USPSTF 
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recommends screening adults for depression in clinical practices that have 
systems in place to assure accurate diagnosis, effective treatment, and follow up. 
The evidence review for screening for alcohol misuse found that for good-quality 
brief, multi-contact behavioral counseling interventions, absolute risk reduction of 
risky and harmful alcohol use by primary care patients was 10.5% (NNT=l0). 6 
Mean drinks per week were reduced 2.9-8.7 compared to controls. There was not 
sufficient evidence to assess the effects of interventions on morbidity and 
mortality. The USPSTF gave screening for alcohol misuse a "B" 
recommendation.7 The Task Force recommended in favor of screening and 
behavioral counseling interventions to reduce alcohol misuse by adults, including 
pregnant women, in primary care settings. 
Key Questions 
• Was evidence for screening for IPV assessed by the USPSTF -designated 
Evidence-based Practice Center (EPC) in a fair way compared to other 
problems assessed by the USPSTF and its EPC's? 
• Is the recommendation for IPV screening consistent with other USPSTF 
recommendations? 
Methods 
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To answer my key questions I used two sets of criteria, one for evaluating SER's 
and one for evaluating the USPSTF recommendations. The criteria for evaluating 
evidence reviews are as follows: 
I. Is there a focused question, including specific key questions, defined 
outcomes, and defined harms? 
2. Was there an adequate search of the literature for evidence including 
appropriate sources of data, appropriate inclusion and exclusion criteria 
decided upon prior to the literature search, reasonable methods for 
determining article eligibility, and uniform methods of article review? 
3. Was the evaluation of quality of individual studies standardized according to 
USPSTF criteria? 
4. Was the assessment of overall quality of the evidence standardized according 
to USPSTF criteria? 
5. Was the assessment of magnitude of net benefit of screening reasonable based 
on the quality of available evidence? 
To evaluate the USPSTF recommendations on screening for IPV, depression, and 
alcohol misuse, I used the following criteria: 
I. Was the recommendation consistent with the overall quality of evidence for 
the benefits of screening? 
2. Was the recommendation consistent with the overall quality ofthe evidence 
for harms of screening? 
3. Was the recommendation consistent with the net magnitude of benefit found? 
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4. Was the recommendation consistent with the net magnitude of harm found? 
I compared and contrasted the three different sets of recommendations issued by 
the USPSTF based on these questions. 
Results 
Key Questions on Screening for IPV 
All three SER' s included specific key questions, but there were some important 
differences in what they asked. The EPC that conducted the SER on screening for 
IPV asked the following key questions: 
1. How well does screening identify current harm or risk for harm from IPV? 
2. What are the adverse effects of screening? 
3. How well do interventions reduce harm from IPV? 
4. What are the adverse effects of interventions? 
5. Does screening for IPV reduce harm, premature death, and disability? 
Key Questions on Screening for Depression 
The EPC that conducted the SER on screening for depression asked three key 
questions that were similar to questions 1, 3, and 5 asked by the IPV group: 
I. What is the accuracy of screening instruments for depression in primary care 
populations? 
2. Is treatment of depression in primary care patients effective in improving 
outcomes? 
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3. Is screening more effective than usual care in identifYing patients with 
depression, facilitating treatment of patients with depression, and improving 
outcomes? 
Key Questions on Screening for Alcohol Misuse 
The key questions asked in the SER for screening and behavioral interventions for 
alcohol misuse were as follows: 
I. Is there direct evidence that behavioral counseling interventions to reduce risky 
or harmful alcohol use reduce morbidity and/or mortality? 
2. What methods were used to identifY target populations for behavioral 
counseling interventions in primary care? 
3. What are adverse effects associated with alcohol use screening and screening-
related assessment? 
4. Does behavioral counseling intervention in primary care reduce risky or 
harmful alcohol use in the targeted subgroup? What are the essential elements of 
efficacious interventions? 
5. Are there other positive outcomes from behavioral counseling interventions to 
reduce risky/harmful alcohol use? 
6. What are adverse effects associated with behavioral counseling interventions 
for risky/harmful alcohol use? 
7. What health care system influences are present in effective screening and 
screening-related assessments and interventions to reduce risky/harmful alcohol 
use or its outcomes? 
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Comparison of Key Questions 
The difference in the sets of key questions for screening for IPV and screening for 
depression may have resulted in a differential assessment of harms between the 
IPV and depression SER's and, consequently, the recommendations that followed 
each. The IPV group gave more weight to adverse effects of screening and 
interventions by making each of them a key question. The depression group cited 
a lack of evidence about adverse effects as a problem in the Results section of the 
SER, but the examination of adverse effects was not given the status of "key 
question." 
As with the IPV paper, the EPC evaluating evidence on screening and behavioral 
interventions for alcohol misuse designated two key questions for asking about 
adverse effects, those associated with screening and those associated with 
behavioral counseling interventions. 
The papers were inconsistent in the way they dealt with the evaluation of 
screening instruments. The IPV and depression papers both had key questions 
that specifically asked about the accuracy of screening instruments; whereas the 
alcohol misuse paper instead asked, "What methods were used to identify target 
populations for behavioral counseling interventions in primary care?'' without 
examining studies on the accuracy of screening instruments. This discrepancy 
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may have created a lesser burden of evidence for the alcohol misuse review than 
for the other two reviews. 
The papers also had different approaches to answering the question of how 
interventions impacted outcomes. First, both the IPV and depression review 
articles asked one key question about how interventions affected outcomes in 
general. The alcohol misuse paper asked three different key questions about 
outcomes, which included morbidity, mortality, risky or harmful alcohol use, and 
"other positive outcomes." 
Finally, both the IPV and depression groups searched for evidence about the 
effects of screening on outcomes, but the IPV group sought data about harm, 
premature death, and disability, none of which were found. The depression group 
was seeking data on the effect of screening on rate of diagnosis, rate of treatment, 
and non-specific "outcomes" compared to usual care, which it was able to find. 
My own search of the literature for studies on the effect of screening for IPV on 
rate of detection of violence, rate of treatment, questionnaire scores, and other 
outcomes revealed one article that would have been included if the authors had 
allowed these as outcomes. It was a systematic review article that concluded that 
there is insufficient evidence of benefit to recommend in favor of implementing 
screening programs. 8 The alcohol misuse SER did not include a question about 
the effects of screening on outcomes, another discrepancy between its key 
questions and those of the other two SER' s. 
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Defined Outcomes 
IPV screening outcomes included: 
1. Patient -oriented outcomes like indicators of physical abuse, neglect, emotional 
abuse, sexual abuse, and related health outcomes if reported such as depression. 
2. How well a screening instrument compared to a standard. 
3. Outcomes for evaluating studies on interventions: scores on Severity of 
Violence Against Women Scale, which includes questions about frequency of 
threats and actual physical and sexual violence. 
Depression screening outcomes included: 
I. Patient oriented outcomes like recovery from or improvement in depression 
after certain period of time and mean months of depression in I year 
2. Sensitivity, specificity, ±LR of screening instruments. 
3. Intermediate outcomes like improvement in SCL-20 score,% reduction in 
depressive severity score, rate of diagnosis, rate of treatment, % with > 12 point 
decrease on SDS at 1 month,% with HAM-D<IO at 6 months, Mean GHQ at 6 
months, Zung scale score,% depressed at 3 months DSM-IIIR criteria,% with <1 
DSM-IIIR criteria symptoms,% depressed at 6 months,% depressed at 12 
months, % depressed at 24 months, mean months of depression in 1 year, % with 
>12 point decrease on SDS at I month,% with HAM-D<10 at 6 months. 
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Alcohol misuse screening and behavioral counseling interventions outcomes 
included: 
1. Patient -oriented outcomes like reduced morbidity and mortality and "other 
positive outcomes." 
2. 3 primary alcohol use outcome categories: 
1. average consumption (mean drinks per week) 
2. binge use (proportion bingeing) 
3. safe/moderate/recommended use (based on attaining each study's 
recommended limits on average consumption and/or binge us) 
The disparity in defined outcomes reflected the disparity in key questions, with 
the alcohol misuse group neglecting to evaluate any outcome reflecting the 
accuracy of screening instruments. All three defined some outcomes 
quantitatively and left room for more open-ended outcomes to emerge. 
Harms of Screening 
The same amount of evidence was found on the adverse effects of screening for 
all three problems. However, the assessment of potential adverse effects, which 
in no case was based on any evidence, was different in the three SER' s. The only 
potential adverse effect considered in the alcohol misuse SER was the potential 
for offending patients. The depression group discussed a longer list of potential 
adverse effects: false-positive results, adverse effects of treatment, adverse 
effects and costs of treatment for false-positives, and potential adverse effects of 
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labeling. The IPV group listed some potential adverse effects that were similar to 
those listed for the depression group like false-negatives discouraging inhibiting 
identification of those at risk, and false-positives leading to "inappropriate 
labeling and punitive attitudes." The IPV group also enumerated potential 
adverse effects that were more severe than those mentioned for depression and 
alcohol misuse screening without any additional evidence to warrant them. These 
potential consequences included psychological distress, escalation of abuse and 
family tension, loss of personal residence and financial resources, erosion of 
established family structure, loss of autonomy for the victim, lost time from work, 
and homicide. 
Data Sources 
Sources of data were comparable for the IPV, depression, and alcohol misuse 
SER's. The IPV group searched MEDLINE, Cochrane Register, PsychiNFO, 
CINAHL, Health & Psychosocial Instruments, reference lists of systematic 
reviews, and experts. The depression EPC used MEDLINE, Cochrane database 
on depression, neurosis, and anxiety disorders, and bibliographies of SR's, 
original articles, Guide to Clinical Preventive Services, and the AHCPR 1993 
Clinical Practice Guideline on Depression. The authors of the SER on screening 
and behavioral interventions for alcohol misuse used the Cochrane Database of 
Systematic Reviews and Database of Research Effectiveness, bibliographies of 
SR' s, unpublished studies located through expert contacts and referrals, 1996 
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Guide to Clinical Preventive Services, MEDLINE, Cochrane Controlled Clinical 
Trials, Psychlnfo, HealthSTAR, and CINAHL from 1994-April2002. 
Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria for each SER are described in Table 1. The 
criteria were similar for all three. One difference for the SER for IPV was that it 
included studies that were conducted in primary care, ob-gyn, and emergency 
room settings, excluding studies of patients presenting with trauma The other 
two SER' s included studies done in primary care and community settings but 
excluded those that were conducted in emergency departments. The IPV SER 
seemed to be more inclusive than the other two SER's. 
The SER for screening for depression stated that inclusion and exclusion criteria 
were agreed upon prior to performing a search of the literature. Neither the 
authors ofthe IPV SER nor the authors ofthe SER on screening for alcohol 
misuse stated whether such criteria were established prior to searching for 
evidence. 
The method for determining eligibility for inclusion in the SER was not specified 
by the IPV authors. The depression group stated that two reviewers 
independently reviewed titles and abstracts of articles identified by literature 
searches and excluded ones which they agreed did not meet eligibility criteria. 
When they disagreed, all authors reviewed full articles and reached consensus 
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about inclusion. For the SER of screening and behavioral interventions for 
alcohol misuse, one investigator reviewed 4,331 titles and abstracts, and a second 
investigator reviewed a random 3 5% of titles and abstracts for agreement. 
Approximately 95% agreement was found, and no articles that met review 
inclusion criteria were coded differently by the two reviewers. Seventeen studies 
met setting and quality criteria, but one did not have study results in time for the 
SER. Twelve of the sixteen reviewed studies addressed non-pregnant adults and 
were included in the SER. 
Methods of Article Review 
All three SER's had similar methods for review articles, though the alcohol 
misuse group described their methods in more detail. The IPV group abstracted 
study design, number of participants, setting, length and type of interventions, 
length of follow-up, outcomes, methods of outcome measurement, and study 
duration of each study. The depression group abstracted study design and 
outcomes data from articles on screening accuracy, screening outcomes, and 
treatment. These data were used to construct evidence tables. For alcohol 
misuse, one primary reviewer abstracted relevant information for many more 
categories than were included in the other two SER's. All data in evidence tables 
were checked by a second reviewer and articles excluded for quality or relevance 
were listed in Table I 0 of the Appendix. Abstracted data included author, year 
published, type of trial, setting, definition of a standard drink used in the study, 
total number randomized to the study, proportion of female and non-white 
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participants, baseline alcohol consumption, proportion that was alcohol 
dependent, and proportion that was motivated, help-seeking, or thought they had a 
problem with alcohol. The alcohol misuse SER was the most explicit about 
outcomes that were abstracted, including mean drinks per week or reduction in 
mean drinks per week, percentage of participants without binge drinking (usually 
defined as more than four drinks per occasion), and percentage of participants 
achieving recommended drinking levels or patterns as defined by the individual 
studies. 
Methods of Evaluating Quality of Individual Studies 
The methods for evaluating the quality of individual studies were similar for all 
three SER's. In the IPV SER, two reviewers independently rated each study's 
quality using criteria specific to different study designs developed by the 
USPSTF. Each study was categorized as good, fair, or poor. When reviewers 
disagreed, a final score was reached "through consensus." In the depression SER, 
internal and external validity for each article were rated separately using criteria 
developed by the USPSTF. The criteria for determining internal validity were 
described and were exactly the same as those used by the IPV authors. In the 
SER on screening and interventions for alcohol misuse, the quality of the articles 
was graded using the same USPSTF criteria, supplemented by guidelines on 
evaluating study randomization, attrition, and intention-to treat analyses from the 
Cochrane Drug and Alcohol Group. The final quality rating for each study was 
assigned "by consensus" of the investigator team. 
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Evaluation of Quality of Individual Studies 
To answer the question of how accurate screening instruments are, the IPV SER 
found four good-quality studies, seven fair-quality studies, and three poor-quality 
studies, as defined by the USPSTF. The depression SER found many more 
studies addressing the accuracy of instruments designed to screen for depression: 
twenty-three good-quality studies and eighteen fair-quality studies. The alcohol 
misuse SER did not seek evidence on the accuracy of screening instruments, and 
none was included in the final evidence review. 
The IPV SER found two fair-quality studies on the effectiveness of interventions 
for IPV while the authors of the depression review found eight good-quality 
studies and eleven fair-quality studies on the effectiveness of either 
pharmacotherapy or psychotherapy at treating depression. The alcohol misuse 
SER included seven good-quality studies and five fair-quality; this group 
excluded poor-quality studies from eligibility for the SER. There was a large 
disparity in the amount of evidence available for the three different SER's and a 
notable lack of any good-quality studies on the effectiveness of interventions 
designed to improve outcomes for IPV. 
No studies of any quality were found that addressed the question of adverse 
effects due to either screening or interventions for any of these health problems. 
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There was no difference in the evidence for adverse effects among the SER's 
since none was found for any of the three topics covered in this review. 
The authors of the IPV SER sought studies on the effects of screening on harm, 
premature death, and disability, but none was available that met the eligibility 
criteria for the review. In evaluating the clinical outcomes of screening, the 
authors of the depression SER asked the question about outcomes in terms of the 
rate of diagnosis of depression, the rate of treatment, and any other outcomes of 
screening. They found eight good-quality studies and five fair-quality studies that 
evaluated the effect of screening on diagnosis, care, and outcomes. If the authors 
of the IPV SER had expanded the outcomes beyond premature death, disability 
and "harm," more similar to the outcomes evaluated by the authors of the 
depression study, they may have found more than the two outcomes studies that 
were ultimately included. A quick search ofMEDLINE for "outcomes of 
screening" and "intimate partner violence" revealed at least one more systematic 
review that appears to meet the SER's inclusion and exclusion criteria.8 
However, that systematic review concluded that there was insufficient evidence to 
recommend for universal screening. The authors of the review of screening and 
behavioral interventions for alcohol misuse did not seek or find evidence of the 
effects of screening on outcomes. 
Methods of Evaluating Overall Quality of Evidence 
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The methods for evaluating the overall quality of the evidence were not discussed 
by the authors of the IPV SER. However, a summary-of-evidence table included 
an assessment of internal and external validity, but not coherence (number of 
studies, homogeneity of those studies, precision of findings, and direction of 
results). The authors of the depression SER described their methods for 
evaluating the overall quality ofthe evidence as follows: they rated the aggregate 
internal validity, external validity, and coherence for each of the key questions. 
These three ratings were combined to rate the overall quality of evidence. The 
SER for screening and behavioral interventions for alcohol misuse described a 
process identical to the one used in the SER for screening for depression. 
Evaluation of the Overall Quality of Evidence for Screening for IPV 
The IPV screening review rated the overall quality of evidence separately for the 
accuracy of screening instruments and for the efficacy of interventions. The 
overall quality of evidence for the accuracy of screening instruments was assessed 
as "poor-good" for non-randomized controlled trials. Screening instruments were 
found to have fair-good correlation with longer instruments, but the authors were 
concerned that there were no studies of instruments that followed women 
longitudinally. The external validity was not given a rating, but the authors noted 
that several instruments were tested using a variety of settings and populations. 
The overall quality of evidence for the efficacy of interventions was assessed as 
"fair" for one randomized controlled trial and one controlled trial without 
randomization. External validity was a problem for these trials because the study 
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populations were small and included only pregnant women. No evidence was 
found on the effects of screening on clinical outcomes, nor on adverse effects of 
screening or interventions. 
Evaluation of the Overall Quality of Evidence for Screening for Depression 
The SER for screening for depression evaluated the overall quality ofthe 
evidence on accuracy of screening instrument and efficacy of treatments as well 
the effects of screening on diagnosis, care, and outcomes. The investigators 
found good overall internal and external validity and good coherence for the 
studies on the accuracy of instruments designed to screen for depression in adults. 
They found good overall internal and external validity and good coherence for the 
studies on the effectiveness of pharmacotherapy in adults. They found fair overall 
internal validity and good overall external validity and coherence for the 
effectiveness of psychotherapy in adults. The investigators assessed the studies 
on the effects of screening on diagnosis, care, and outcomes as having good 
internal and external validity, but only fair-poor coherence. No evidence was 
found on the topic of adverse effects of depression screening and interventions. 
Evaluation of the Overall Quality of Evidence for Screening and Behavioral 
Interventions for Alcohol Misuse 
The authors of the SER on screening and behavioral interventions for alcohol 
misuse evaluated the overall quality of evidence available for each of the seven 
key questions they asked. They found fair overall evidence that behavioral 
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counseling interventions to reduce harmful alcohol use actually reduce morbidity 
and/or mortality. They found fair overall evidence about which methods were 
useful for identifying target populations for behavioral counseling interventions in 
primary care. They found poor overall evidence on adverse effects associated 
with alcohol use screening and screening-related assessment. They rated 
evidence on whether behavioral counseling interventions in primary care reduces 
risky or harmful alcohol use as poor-fair quality overall. They found poor-fair 
overall evidence for other positive outcomes from behavioral counseling 
interventions. There was poor overall evidence on the adverse effects associated 
with behavioral counseling interventions. Finally, they evaluated evidence on 
"health care system influences" that are present in effective screening and 
screening-related assessments and interventions as being of fair overall quality. 
Direction and Magnitude of the Evidence for IPV Screening and Interventions 
Screening instruments for IPV were found to have fair-good correlation with 
longer instruments. Two studies of interventions "suggest benefit using self-
reported outcomes," but the magnitude of increased detection was not reported by 
the SER. Both used the Severity of Violence Against Women Scale (SVA WS) to 
evaluate the screening instruments. One of these studies found that one 
intervention consisting of "unlimited access to counseling services of a 
... professional counselor with expertise in domestic violence," and the services of 
a "mentor mother" who "offered support, education, referral, and assistance in 
accessing community resources through personal visits and telephone contacts" 
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had significantly lower (p<0.05) physical violence scores on the SV A WS two 
months following initiation of the intervention than those who received only 
professional counseling (adjusted means of 34.7 and 39.5, respectively).9 
However, the physical violence score for those who received professional 
counseling and a "mentor mother" were not significantly lower than for those who 
received only a brief intervention consisting of "a wallet -sized resource card that 
included phone numbers of local agencies to assist with domestic violence" and 
"information about plarming for personal safety" (adjusted mean of38.2). No 
evidence was found for the effects of screening on clinical out comes nor for the 
adverse effects of screening or interventions. 
The second study included in the IPV SER on the effects of interventions on 
outcomes found differences between the intervention group whose participants 
received a "one-to-one interview conducted by ... nurses who had received a 
minimum of 4 hours training with the investigator" along with "information on 
applying for legal protection orders and filing criminal charges, and community 
resource phone numbers such as the shelter, hot lines, and law enforcement" and 
the comparison group whose participants received only a "wallet-sized card with 
information on community resources for abuse, including the crisis hot line, the 
shelter, and law enforcement."10 The authors found higher mean SVA WS scores 
for threats and physical violence in the comparison group than in the intervention 
group (33.4 vs. 27.3 for threats; 35.9 vs. 33.1 for actual violence) six months 
following the initiation of intervention. However, the comparison group started 
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out with higher mean scores than the intervention group at the time of entry into 
the study (46.4 vs. 39.1 for threats; 52.0 vs. 47.9 for actual violence), and it is 
unclear from the study which of these differences is statistically significant. 
Direction and Magnitude of the Evidence for Depression Screening and 
Interventions 
Screening instruments for depression were found to improve the rate of detection 
of depression by 10-47%. The use of pharmacologic interventions resulted in a 
10-30% absolute risk reduction for main outcomes, including HAM-D score 
reduction and recovery from depression. Investigators reported that 
psychotherapeutic interventions appeared as effective as antidepressant 
interventions. No evidence was found on the adverse effects of screening or 
interventions. The effects of screening on clinical outcomes were mixed in 
different studies. Two small older trials found large improvements in depression. 
Two larger good quality trials found moderate improvements (9%) in recovery 
from depression. Four other studies found small or no improvements in clinical 
outcomes for those who had been screened. 
Direction and Magnitude of the Evidence for Alcohol Misuse Screening and 
Interventions 
Studies found by the investigators that addressed the question of whether 
interventions for alcohol misuse reduce morbidity or mortality produced mixed 
results: in two of four studies examining problem scores, those in all groups 
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improved with no differences between intervention and control groups at follow-
up. Two other studies showed no changes from baseline to follow-up within or 
between groups. With other outcomes, studies generally found no improvement 
or similar improvements in interventions and controls over the duration of the 
trials. Of the five trials that examined health care utilization, only one found 
reduced self-reported hospital days at twelve months. In one good-quality trial 
there was a trend toward reduced all-cause mortality in interventions compared to 
controls (three vs. seven deaths; p>O.l ). In a second study a brief single-contact 
intervention had no long-term effects on morbidity, mortality, or alcohol 
consumption at ten-year follow-up. A third study found that men who received an 
intervention had a significantly lower total mortality rate (24/1 00,000 person-
years) than non-invited controls (30/100,000 person-years) (p<0.02) and had 
significantly reduced alcohol-related mortality after 3 to 21 years. 
Various methods were used to identify target populations for behavioral 
counseling interventions in primary care, including screening (identifying patients 
with probable risky/harmful alcohol use) and screening-related assessment 
(confirming screening results and distinguishing patients suitable for brief 
interventions from those needing specialty care referral). Screening usually 
involved self-administered questionnaires or brief interviews to assess average 
quantity or frequency and binge use. 
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The investigators found that screening and interventions integrated into primary 
care reduce alcohol consumption and improve use patterns: four good-quality 
trials reported that weekly drinking was reduced 13-34% compared to controls, 
resulting in 2.9-8.7 fewer mean drinks per week at follow-up in intervention 
group compared to control group. One good-quality trial did not find significant 
change in average use. All five good-quality trials found significant effects on 
recommended or sage alcohol use, resulting in 1 0-19% more intervention 
participants than controls reporting recommended or safe drinking patterns. Two 
of four good-quality trials reported significantly reduced binge drinking. 
The investigators found that there are often health care system influences present 
in effective screening and screening-related assessments and interventions to 
reduce risky/harmful alcohol use or its outcomes. In all 12 trials, additional staff 
or systems support were required to provide screening and assessment services 
and sometimes intervention support. In nearly every study, research staff 
conducted the screening and assessment outside the routine care encounter. Most 
of these processes took more than 30 minutes. Provider training sessions ranged 
from fifteen minutes to 2. 5 hours. Only three studies used incentives for 
participating providers or patients. Besides usual care physicians, studies also 
used research staff or non-physician health care staff to deliver some or all of the 
intervention. Research staff often performed important support functions like 
prompting the provider and supplying intervention materials to the chart. 
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No studies were found that addressed what adverse effects were associated with 
alcohol use screening or assessment. No studies were found that addressed the 
question of what adverse effects were associated with behavioral counseling 
interventions for risky or harmful alcohol use. No other positive outcomes from 
behavioral counseling interventions emerged. "Null findings may reflect lack of 
an effect, lack of appropriate measures, and/or reduced power for secondary 
analyses." 
IPV Recommendations 
Next I examined the consistency of each recommendation statement with the 
overall quality of the evidence and the net benefit found for each key question in 
its corresponding SER. For the question of accuracy of IPV screening 
instruments the SER found four good quality studies and two fair studies that all 
showed good correlation (R=0.69-0.85) between screening instruments and longer 
questionnaires. It also found three studies rated "poor" because they used an 
interview as the reference standard, but the interview was not defined. In each of 
these studies the screening instruments yielded a higher rate of detection of IPV 
(14% vs. 0.4%, 85% vs. 59%, and 41% vs. 14%). In the Discussion section of 
the Recommendation Statement, the USPSTF wrote, "Newer brief instruments 
designed to identify women who are victims of IPV in primary care settings 
compare well with lengthier, previously validated instruments," but in the 
Summary section of the same paper, they wrote, "The USPSTF found no existing 
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studies that determine the accuracy of screening tools for identifying ... IPV 
among ... women in the general population." 
To answer the question of how effective interventions are for IPV, the SER found 
two fair quality studies that indicated interventions improved self-reported 
outcomes. One study compared three interventions (card with resources vs. 
unlimited access to counselor in clinic vs. counseling plus "mentor mother" in 
community).9 According to the USPSTF's SER, "abuse decreased significantly in 
all groups with no significant differences between the groups." However, a 
careful reading of the original paper revealed that the counseling plus "mentor 
mother" group had significantly lower physical violence scores on the SV A WS 
two months following initiation of intervention than those who received only 
counseling. 
The other study on IPV outcomes compared two interventions (three counseling 
sessions vs. card with resources). The IPV SER stated that less violence occurred 
in the intervention group at six and twelve months using the SV A WS (p=0.052) 
and using the Index of Spouse Abuse (ISA) (p=0.007).10 The Discussion section 
of Recommendation Statement said, "both studies ... showed a trend (not 
statistically significant) in women reporting decreased violence after brief 
counseling or outreach interventions." In fact, both studies produced results that 
showed a statistically significant difference between different types of 
interventions. The first study showed that the support of a "mentor mother" was 
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associated with significantly lower physical violence scores on the SV A WS; the 
second showed significantly less violence using the ISA instrument and an 
arguably significant difference using the SV A WS. However, given the fair 
quality of the studies and the fact that in the second study participants were not 
assigned to intervention groups randomly, the Summary of Recommendation 
accurately stated, "The USPSTF found limited evidence as to whether 
interventions reduce harm to women." 
On the question of effect of screening on harm, premature death, and disability for 
IPV, the SER found no evidence on the effect of screening on harm, premature 
death, and disability for IPV. In the Discussion section of the Recommendation 
Statement the USPSTF wrote, "No studies were found that directly addressed the 
impact of screening on reducing harmful outcomes." The Summary of 
Recommendation states, "The USPSTF found no direct evidence that screening 
for family and intimate partner violence leads to decreased disability or premature 
death." 
The USPSTF Recommendation Statement for IPV reflected the findings in the 
SER on the adverse effects ofiPV screening, but it treats the same amount of 
evidence differently in the IPV Recommendation Statement than in either the 
depression or the alcohol misuse Recommendation Statement. The SER found no 
evidence on the adverse effects of IPV screening. The USPSTF stated in the 
Discussion section of its Recommendation statement, "No studies have directly 
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addressed the harms of screening and intervention for. . .IPV. False-positive test 
results, most common in low-risk populations, may compromise the clinician-
patient relationship. Additional possible harms of screening may include loss of 
contact with established support systems, psychological distress, and an escalation 
of abuse. However, none of these potential harms has been studied." In the 
Summary it was reiterated that "no studies have directly addressed the harms of 
screening and interventions for ... IPV. As a result, the USPSTF could not 
determine the balance between the benefits and harms of screening for. . .IPV." 
Depression Recommendations 
Regarding the question of accuracy of depression screening instruments, the SER 
found "good" overall quality of evidence that screening improved rate of 
detection by 10-47%. In the Recommendation Statement, the USPSTF stated that 
"most instruments have relatively good sensitivity but only fair specificity." 
"Assuming ... a prevalence of major depression of 5-l 0% in primary care settings, 
about 24-40% of patients who screen positive will have major depression." This 
is consistent with the Summary of Recommendations, which stated "The USPSTF 
found good evidence that screening improves the accurate identification of 
depressed patients in primary care settings." 
The SER for depression found good internal and external validity and coherence 
for studies that showed moderate benefits for pharmacotherapy. It found fair 
internal validity and good external validity and coherence for studies that showed 
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moderate benefits for psychotherapy. Treatment resulted in about 10-30% ARR 
for main outcomes for both pharmacotherapy and psychotherapy. In the 
Recommendation Statement the USPSTF wrote, "Antidepressant medications for 
major depression ... are clearly more effective than placebo," and "Psychosocial 
and psychotherapeutic interventions are probably as effective as antidepressant 
medications for major depression." The Summary of Recommendations stated, 
"The USPSTF found good evidence ... that treatment of depressed adults identified 
in primary care settings decreases clinical morbidity." 
The question on the effects of screening for depression asked about diagnosis, 
care, and outcomes for depression, rather than harm, premature death, and 
disability like in the IPV paper. The SER characterized the studies evaluating the 
effect of screening on patient-oriented outcomes as having good internal and 
external validity and fair-poor coherence. The effects of screening on outcomes 
were mixed. In the Recommendation Statement the USPSTF described the trials 
that demonstrated positive effects of screening and those that showed no effect. 
The Summary of Recommendations states, "Trials that have directly evaluated the 
effect of screening on clinical outcomes have shown mixed results." The 
Recommendation statement was consistent with the quality, direction, and 
magnitude of the evidence reported in the SER. 
Like the IPV SER, the depression SER found no evidence on the adverse effects 
of depression screening. The USPSTF stated in the Discussion section of its 
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Recommendation statement, "The potential harms of screening include false-
positive screening results, the inconvenience of further diagnostic work-up, the 
adverse effects and costs of treatment for patients who are incorrectly identified as 
being depressed, and potential adverse effects oflabeling. None of the research 
reviewed provided useful empirical data regarding these potential adverse 
effects." In the Summary the authors wrote, "The USPSTF concluded the 
benefits of screening are likely to outweigh any potential harms" without any 
mention of the lack of evidence on harms. 
Alcohol Misuse Recommendations 
The authors of the SER on screening and behavioral interventions for alcohol 
misuse discovered various methods for identifYing target populations for 
behavioral counseling interventions in primary care: screening (identifYing 
patients with probable risky/harmful alcohol use) and screening-related 
assessment (confirming screening results and distinguishing patients suitable for 
brief interventions from those needing specialty care referral). Screening usually 
involved self-administered questionnaires or brief interviews to assess average 
quantity or frequency and binge use. Unlike IPV and depression, the authors did 
not determine the extent to which screening improved the rate of detection of 
risky or harmful alcohol use. In fact, accuracy of screening instruments was not a 
question posed by the authors of the review, who instead asked, "What methods 
were used to identifY risky/harmful drinkers for behavioral counseling 
interventions in primary care?'' Because of this discrepancy, it seemed 
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misleading for the USPSTF to write in the Recommendation Statement, "The 
USPSTF found good evidence that screening in primary care settings can 
accurately identify patients whose levels or patterns of alcohol 
consurnption ... place them at risk for increased morbidity and mortality ... " 
The USPSTF recommendation for screening and behavioral interventions for 
alcohol misuse was consistent with the SER findings. The SER concluded that 
screening and interventions integrated into primary care reduce alcohol 
consumption and improve use patterns: four good-quality trials reported that 
weekly drinking was reduced 13-34% compared to controls, resulting in 2.9-8. 7 
fewer mean drinks per week at follow-up in intervention group compared to 
control group. One good-quality trial did not find a significant change in average 
use. All five good-quality trials found significant effects on recommended or 
sage alcohol use, resulting in 1 0-19% more intervention participants than controls 
reporting recommended or safe drinking patterns. Two of four good-quality trials 
reported significantly reduced binge drinking. Correspondingly, the USPSTF 
reported in the Recommendation Statement, "good evidence that brief behavioral 
counseling interventions with follow-up produce small to moderate reductions in 
alcohol consumption that are sustained over 6- to 12-month periods or longer." 
Unlike the authors of the SER's on IPV and depression, the authors of the SER 
for alcohol misuse did not include in their list of key questions one about the 
effects of screening on health outcomes. Instead they asked, "Is there direct 
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evidence that behavioral counseling interventions to reduce risky or harmful 
alcohol use reduce morbidity and/or mortality?" Eligible studies produced mixed 
results, which are described above. In their Recommendation Statement the Task 
Force wrote, "The USPSTF found some evidence that interventions lead to 
positive health outcomes 4 or more years post-intervention, but found limited 
evidence that screening and behavioral counseling reduce alcohol-related 
morbidity." The Recommendation Statement is consistent with the quality of the 
evidence and the magnitude of benefit found. 
The SER on screening and behavioral interventions for alcohol misuse reported 
that no studies were found that addressed adverse effects associated with alcohol 
use screening or assessment or with behavioral counseling interventions for 
alcohol use. The USPSTF mentioned in the Discussion section of the 
Recommendation Statement that little evidence was found to address the question 
of the magnitude of harms of screening and behavioral counseling interventions. 
In contrast to IPV Recommendation Statement, the lack of harms was not stated 
in the Summary of Recommendations, which, parallel to the depression 
recommendation, stated, "The USPSTF concluded that the benefits of behavioral 
counseling interventions to reduce alcohol misuse by adults outweigh any 
potential harms." 
Conclusions 
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It is likely that evidence for screening for IPV was not assessed in a fair way 
compared to other problems addressed by the USPSTF. The USPSTF 
Recommendation for screening for IPV was not consistent with recommendations 
for comparable health problems. However, it is unlikely that the recommendation 
for screening for IPV would be different if disparities in assessment and synthesis 
were addressed. 
The largest discrepancy among the three sets of guidelines was the different 
speculation and emphasis placed on adverse effects of screening and 
interventions. It is unclear why a lack of evidence on adverse effects caused the 
USPSTF to declare in its Recommendation Statement on screening for IPV that it 
was unable to determine the balance between benefits and the harms, but the same 
lack of evidence for screening for depression and screening and behavioral 
interventions for alcohol misuse did not prevent the USPSTF from issuing a B 
recommendation and stating that there is at least fair evidence that the benefits of 
screening outweigh harms for those two health problems. 
Nonetheless, it is clear that there is much less evidence available on the effects of 
screening and interventions for IPV than for depression and for alcohol misuse. 
The USPSTF assessment that there is insufficient evidence to recommend in favor 
or against universal screening for IPV is probably correct. Since there appear to 
be several good quality studies demonstrating the usefulness of screening 
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instruments at identifying women at-risk for IPV, what is needed is evidence on 
whether screening leads to interventions that improve outcomes for such women. 
Future Research 
To answer the question of whether the benefits of universal screening for IPV 
outweigh the risks, a randomized controlled trial should be conducted in several 
primary care settings like family practice offices in rural and urban settings as 
well as a hospital-based emergency room. Women in each setting should be 
randomized to screening for IPV or to usual care. It should be determined ahead 
of time the sample size that would be required to detect a significant difference 
between the two comparison groups. Participants should be randomized to either 
the screening group or to the usual care group by a reliable method like using a 
random number table or computer-generated random numbers. Following 
randomization, investigators should ensure that the groups have comparable 
demographic characteristics and do not differ in a way that would contribute to or 
mask differences between the measured outcomes for each of the two groups. 
Patients who are randomized to the screening group should be screened using a 
validated screening instrument like the HITS scale, which asks patients how often 
their partner physically hurt, insulted, threatened, and screamed at them. 11 Within 
72 hours of randomization, patients should be assessed using a "gold standard" 
for measuring intimate partner violence. The most widely used standard is the 
Conflict Tactics Scale (CTS), 11 but the authors of the SER on Screening for 
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Family and Intimate Partner Violence note that, "the Conflict Tactics Scales may 
not have undergone sufficient testing of its validity to qualify as a gold standard" 
(cite SER). The person conducting the assessment using the CTS or other 
standard should be blinded to the screening results. 
Following screening, those participants who are identified as having an increased 
risk of experiencing abuse should receive and intervention consisting of, at a 
minimum, education about intimate partner violence and referral to a program or 
agency that provides support for victims of IPV. Interventions taken by clinicians 
following the screening vs. usual care stage should be assessed by reviewing the 
medical records of participants. Patients should be classified as having been 
treated for IPV if the medical record documented counseling for or education 
about IPV and a referral to a mental health provider or community agency that 
provides support for victims ofiPV. Patient and physician satisfaction should be 
assessed using an instrument such as Likert scales. 12 
Patients in the usual care and screening groups should be assessed at three 
months, six months, one year, two years, five years, and ten years following the 
begiuning ofthe study. One instrument that has been used to measure outcomes 
of interventions for IPV in the past is the Severity of Violence Against Women 
Scale (SV A WS). It measures threats of physical violence, actual physical 
violence, and sexual abuse.9•10 Other outcomes that ought to be measured include 
homicide, suicide, all-cause mortality, ER visits, spontaneous abortion, quality of 
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life, and psychiatric disorders like depression and anxiety. These outcomes 
should be measured in a way that they would be assessed equivalently whether 
they were positively or negatively influenced by screening. 
Only a randomized controlled trial would provide evidence that would answer the 
question of whether the risks of screening outweigh the benefits. The more 
women that can be followed for longer periods of time, the more information will 
be gained. Consultation with a member of the University of North Carolina-
Chapel Hill's Institutional Review Board revealed that this design would likely be 
approved. She anticipated that the biggest challenge being the ability to ensure 
confidentiality for the participants. Especially concerning would be how to 
contact them for follow-up so that their partners would not be alerted to their 
status as a study participant. Solutions to this problem include using only contact 
information to which the participants consent, not leaving messages for the 
participants, not sending letters or e-mail messages, clarifying times when it is 
safe to call, blocking features like caller ID, and always allowing the participant 
to control when and how she is contacted. 
Limitations 
One limitation of this review is my personal experience as an advocate for 
survivors of domestic and sexual violence since 1998. I have made every effort to 
maintain an unbiased attitude in this examination of USPSTF guidelines but must 
acknowledge my frustration with the lack of choices and resources available to 
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the many women, men, and children who are abused by their own family 
members. To address my own bias I have depended on my advisor and other 
readers to bring to my attention statements and conclusions that are or appear to 
be lacking in objectivity. 
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Table I. Systematic Evidence Review Criteria 
Focused question: key Focused question: defined outcomes Focused question: defined harms 
questions 
IPV I. Accuracy of screening I. Patient-oriented: Harm, premature death, Speculative: false-negatives, false-
instruments? disability (no studies were found) positives, psychological distress, 
2. Adverse effects of 2. Studies on instruments: how well escalation of abuse and family 
screening? instrument in question correlated with tension, loss of personal residence 
3. How well do previously validated instrument (standard and financial resources, erosion of 
interventions reduce instrument varied) established family structure, loss of 
harm? 3. Studies on interventions: scores on autonomy for the victim, lost time 
4. Adverse effects of Severity of Violence Against Women from work, and homicide. No 
interventions? Scale evidence found on potential adverse 
5. Does screening reduce effects of either screening or 
harm, premature death, interventions for IPV. 
and disability? 
Depression I. Accuracy of screening I. Sensitivity, specificity, ±LR Speculative: false-pos. results, 
instruments? 2. Recovery from depression, improvement adverse effects of treatment, adverse 
2. Does treatment improve m scores effects and costs of treatment for 
outcomes? 3. Rates of diagnosis and treatment, mean false-pos, potential adverse effects of 
3. Does screening improve months of depression in I year, % with labeling. No evidence found on 
diagnosis, treatment, and improvement on standard questiounaires, potential adverse effects of either 
outcomes better than % depressed after 3 months, 6 months, 12 screening or interventions for 
usual care? months, and 24 months. depression. 
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Focused question: key questions Focused question: defined Focused question: defined 
outcomes harms 
Alcohol 1. Is there direct evidence that behavioral counseling 1. Reduced morbidity and Speculative: potential for 
miSUSe interventions to reduce risky or harmful alcohol use mortality offending patients. No 
reduce morbidity and/or mortality? 2. 3 primary alcohol use evidence found on 
2. What methods were used to identify target outcome categories: potential adverse effects 
populations for behavioral counseling interventions in A. average consumption for either screening or 
primary care? (mean drinks per week) interventions for alcohol 
3. What are adverse effects associated with alcohol use B. binge use (proportion problems. 
screening and screening-related assessment? bingeing) 
4. Does behavioral counseling intervention in primary C. safe/moderate use (based 
care reduce risky or harmful alcohol use in the targeted on attaining each study's 
subgroup? recommended limits on 
4a. What are the essential elements of efficacious average consumption and/or 
interventions? binge us) 
5. Are there other positive outcomes from behavioral 3. Other positive outcomes 
counseling interventions to reduce risky/harmful alcohol 
use? 
6. What are adverse effects associated with behavioral 
counseling interventions for risky/harmful alcohol use? 
7. What health care system influences are present in 
effective screening and screening-related assessments 
and interventions to reduce risky/harmful alcohol use or 
its outcomes? 
42 
Evidence search: sources of data Evidence search: inclusion criteria Evidence search: 
exclusion criteria 
IPV MEDLINE, Cochrane Register, English, applicable to U.S. clinical practice, describes Studies on patients 
PsychiNFO, CINAHL, Health & abuse of women, conducted in primary care, ob-gyn, presenting with trauma, 
Psychosocial Instruments, or ER settings, includes a clinician in process of interventions designed to 
reference lists of SR's, and assessment or intervention. For assessment: educate health care 
experts evaluates assessment procedure, clearly describes professionals or increase 
sample, instrument outcomes, and data collection. screening rates, 
For intervention: measures effectiveness of mandatory reporting laws, 
intervention compared to comparison groups accuracy of physician 
diagnosis and reporting, 
physician factors related 
to reporting, and 
descriptions of programs 
Depression MEDLINE, Cochrane database English, humans, original data only. For assessment: Conducted in hospitals or 
on depression, neurosis, and 1994-1999, includes "criterion standard", measures psychiatry clinics, non-
anxiety disorders, and sensitivity and specificity, conducted in primary care published studies, non-
bibliographies ofSR's, original or community setting. For effectiveness of English, animal studies, 
articles, Guide to Clinical pharmacotherapy: 1994-1999, RCT's, conducted in letters, editorials, non~ 
Preventive Services, and the primary care or community settings. For systematic reviews 
AHCPR 1993 Clinical Practice effectiveness of psychotherapy: 1966-1999, same as 
Guideline on Depression above 
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Evidence search: sources of Evidence search: inclusion criteria Evidence search: exclusion criteria 
data 
Alcohol Key questions 1,4,5,7: English-language reports of randomized or Emergency department or hospital 
miSUSe Cochrane Database of nomandomized controlled clinical trials of setting, non-human, non-English 
Systematic Reviews and nondependent drinkers 12 years of age or abstract, study design (case reports or 
Database of Research older who received a primary care series, letters to editor or editorials, 
Effectiveness, bibliographies behavioral counseling intervention primarily observational studies), population (age 
ofSR's, unpublished studies to reduce alcohols intake. Conducted in < 12 years, dependent drinkers; 
located through expert primary care setting co morbid treatment populations), 
contacts and referrals, 1996 setting (specialty treatment, behavioral 
Guide to Clinical preventive health, community or school without 
Services, MEDLINE, clinic/health care personnel, non-
Cochrane Controlled Clinical comparable cultural setting), 
Trials, Psychlnfo, intervention (no behavioral counseling 
HealthST AR, and CINAHL intervention, intervention delivered in 
from 1994-April 2002 non-replicable ways), poor quality 
Key questions 3 and 6: according to USPSTF criteria; studies 
MEDLINE and Psychlnfo on pregnant women and adolescents. 
1994-April 2002 
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Evidence Evidence search: Method for determining eligibility Evidence search: Methods of article 
search: review 
I/E 
Criteria 
decided on 
prior to lit. 
search? 
IPV No Not specified Abstracted study design, number of 
participants, setting, length and type of 
interventions, length of follow-up, 
outcomes, methods of outcome 
measurement, and study duration of each 
study. 
Depress Yes 2 reviewers independently reviewed titles and abstracts of articles Abstracted study design and outcomes data 
identified by literature searches and excluded ones which they from articles on screening accuracy, 
agreed did not meet eligibility criteria. When they disagreed, all screening outcomes, and treatment. These 
authors reviewed full articles and reached consensus about data were used to construct evidence 
inclusion. tables. 
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Evidence Evidence search: Method for Evidence search: Methods of article review 
search: I/E determining eligibility 
Criteria 
decided on 
prior to lit. 
search? 
Alcohol No One investigator reviewed 4331 non- One primary reviewer abstracted relevant information using 
misuse duplicative titles and abstracts, and a data-abstraction forms. All data in evidence tables were checked 
second investigator reviewed a by a second reviewer and articles excluded for quality or 
random 35% of titles/abstracts for relevance appear in Table 10 of the Appendix. Abstracted 
concordance. Approximately 95% author, year published, type of trial, setting, and definition of a 
agreement was found, and non standard drink used in the study. Abstracted total number 
articles that met review inclusion randomized to the study, proportion of female and non-white 
criteria were discrepantly coded by participants, baseline alcohol consumption, proportion that was 
he 2 reviewers. 17 studies met alcohol dependent, and proportion that was motivated, help-
setting and quality criteria, but 1 did seeking, or thought they had a problem with alcohol. Alcohol 
not have study results in time for the use outcomes measured: I. mean drinks per week or reduction 
SER. 12 ofthe 16 reviewed studies in mean drinks per week. 2. percentage of participants without 
addressed non-pregnant adults and binge drinking (usually defined as >4 drinks per occasion). 3. 
were included in the SER percentage of participants achieving recommended drinking 
levels or patterns (as defined by the study). 
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Methods for evaluating quality of Evaluation of quality of individual Methods for evaluating overall quality 
individual studies studies of the evidence 
IPV 2 reviewers independently rated Accuracy of screening instruments: 4 Not discussed. Summary of evidence 
each study's quality using criteria "good" quality, 7 "fair," 3 "poor." All table included internal and external 
specific to different study designs are non-randomized controlled trials. validity, but not coherence. 
developed by the USPSTF. Each Adverse effects of screening: no 
study was categorized as good, evidence available 
fair, or poor. When reviewers Effectiveness of interventions: 2 studies 
disagreed, a final score was rated "fair." 1 RCT and 1 non-
reached "through consensus." randomized contro lied trial 
Adverse effects of interventions: no 
evidence available 
Effect of screening on harm, premature 
death, and disability: no evidence 
available 
Depression Internal and external validity for Accuracy of screening instruments: 23 Rated the aggregate internal validity, 
each article were rated separately "good," 18 "fair" external validity, and coherence 
using criteria developed by the Effectiveness of interventions: (number of studies, homogeneity of 
USPSTF. The criteria for Pharmacotherapy: 8 "good," 11 "fair" those studies, precision of findings, and 
determining internal validity were Effect of screening on diagnosis, care, direction of results) for each of the key 
described and were exactly the and outcomes: 8 "good," 5 "fair" questions. These 3 ratings were 
same as those used by the IPV combined to rate the overall quality of 
authors. evidence. 
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Methods for evaluating quality Evaluation of quality of individual studies Methods for evaluating 
of individual studies overall quality of the 
evidence 
Alcohol Quality of the articles was KQ 1: 2 "good" and 2 "fair" quality studies "We used the UPSTF 
miSUSe graded using the USPSTF KQ2: 7 "good" and 4 "fair" quality RCT' s; I "fair" approach to grade the 
criteria, supplemented by quality CCT of relevant primary care populations overall quality of 
guidelines on evaluating study KQ3: No studies found evidence for each key 
randomization, attrition, and KQ4: 7 "good" and 4 "fair" quality RCT's; I "fair" question." (As 
intention-to treat analyses from quality CCT of relevant primary care populations (same described above for the 
the Cochrane Drug and Alcohol studies used to answer KQ2) depression paper) 
Group. The final quality rating KQ4a: Same studies examined as in KQ4, but less 
for each study was assigned by information available about the elements of effective 
consensus of the investigator interventions. 
team. KQ5: 3 studies of "limited usefulness" found that 
addressed cost-effectiveness 
KQ6: No studies found 
KQ7: "little information reported about contextual 
factors" 
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Overall assessment of quality of evidence Evaluation of magnitude of net benefit 
IPV Accuracy of screening instruments: Internal validity: Screening instruments: "fair-good correlation" with 
Poor-good. External validity: Several brief instruments longer instruments. 
tested using a variety of settings and populations. 2 intervention trials "suggest benefit using self-
Effectiveness of interventions: Internal validity: Fair reported outcomes." Both used the SVSWS; 
External validity: Studied in small populations of magnitude not reported. 
pregnant women only. No evidence for adverse effects or effect of screening 
on clinical outcomes. 
Depression Accuracy of screening instruments (for adults): Good Screening improved rate of detection by I 0-4 7%. 
internal/external validity and coherence Treatment resulted in 10-30% ARR for main 
Effectiveness of treatments: Good internal/external outcome. 
validity and coherence for pharmacotherapy. Fair No evidence for adverse effects. 
internal validity and good external validity and Effects of screening on outcomes were mixed. 2 
coherence for psychotherapy. found large improvements. 2 found moderate (9%) 
Effect of screening on diagnosis, care, and outcomes: recovery. 4 found small or no improvements. 
Good internal/external validity and fair-poor coherence. 
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Overall assessment of quality of evidence Evaluation of magnitude of net benefit 
Alcohol misuse KQJ: Fair overall evidence KQJ: Mixed results: in 2 of 4 studies examining problem scores, those 
KQ2: Fair overall evidence in all groups improved with no differences between intervention and 
KQ3: Poor overall evidence control groups at follow-up. Other 2 studies showed no changes from 
KQ4: Good overall evidence baseline to follow-up within or between groups. With other outcomes, 
KQ4a: Poor-to-fair overall evidence studies generally found no improvement or similar improvements in 
KQ5: Poor-to-fair overall evidence interventions and controls over the duration of the trials. Of the 5 trials 
KQ6: Poor overall evidence that examined health care utilization only 1 found reduced self-reported 
KQ7: Fair overall evidence hospital days at 12 months. In one good-quality trial there was a trend 
toward reduced all-cause mortality in interventions compared to 
controls (3 vs. 7 deaths; p>0.1 ). In a 2"d study a brief single-contact 
intervention had no long-term effects on morbidity, mortality, or 
alcohol consumption at 1 0-year follow-up. A 3'd study men had 
significantly lower total mortality rate (24/100,000 person-years) than 
non-invited controls (30/100,000 person-years) (p<0.02) and had 
significantly reduced alcohol-related mortality after 3 to 21 years. 
KQ2: Various methods were used: screening (identifying patients with 
probable risky/harmful alcohol use) and screening-related assessment 
(confirming screening results and distinguishing patients suitable for 
brief interventions from those needing specialty care referral). 
Screening usually involved self-administered questionnaires or brief 
interviews to assess average quantity or frequency and binge use. 
KQ3: No studies found that addressed adverse effects associated with 
alcohol use screening or assessment or with behavioral counseling 
interventions for alcohol use. 
KQ4: Screening and interventions integrated into primary care reduce 
alcohol consumption and improve use patterns: 4 good-quality trials 
reported that weekly drinking was reduced 13-34% compared to 
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controls, resulting in 2.9-8.7 fewer mean drinks per week at follow-up 
in intervention group compared to control group. 1 good-quality trial 
did non find significant change in average use. All 5 good-quality 
trials found significant effects on recommended or sage alcohol use, 
resulting in 10-19% more intervention participants than controls 
reporting recommended or safe drinking patterns. 2 of 4 good-quality 
trials reported significantly reduced binge drinking. 
KQ4a: Not enough information available about the elements that make 
an intervention effective. 
KQ5: "Null findings may reflect lack of an effect, lack of appropriate 
measures, and/or reduced power for secondary analyses." 
KQ6: No studies address this question. 
KQ7: In all 12 trials, additional staff or systems support were required 
to provide screening and assessment services and sometimes 
intervention support. In nearly every study, research staff conducted 
the screening and assessment outside the routine care encounter. Most 
of these processes took more than 30 minutes. Provider training 
sessions ranged from 15 min to 2.5 hours. Only 3 studies used 
incentives for participating providers or patients. Besides usual care 
physicians, studies also used research staff or non- physician health 
care staff to deliver some or all of the intervention. Research staff 
often performed important support functions like prompting the 
provider and supplying intervention materials to the chart. 
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